Your browser doesn't support javascript.
loading
Adjuvant ovarian function suppression and cognitive function in women with breast cancer.
Phillips, Kelly-Anne; Regan, Meredith M; Ribi, Karin; Francis, Prudence A; Puglisi, Fabio; Bellet, Meritxell; Spazzapan, Simon; Karlsson, Per; Budman, Daniel R; Zaman, Khalil; Abdi, Ehtesham A; Domchek, Susan M; Feng, Yang; Price, Karen N; Coates, Alan S; Gelber, Richard D; Maruff, Paul; Boyle, Frances; Forbes, John F; Ahles, Tim; Fleming, Gini F; Bernhard, Jürg.
Afiliação
  • Phillips KA; Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia.
  • Regan MM; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia.
  • Ribi K; Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia.
  • Francis PA; International Breast Cancer Study Group, Bern CH-3008, Switzerland.
  • Puglisi F; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
  • Bellet M; Harvard Medical School, Department of Medicine, Boston, MA 02115, USA.
  • Spazzapan S; International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland.
  • Karlsson P; Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia.
  • Budman DR; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia.
  • Zaman K; Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia.
  • Abdi EA; International Breast Cancer Study Group, Bern CH-3008, Switzerland.
  • Domchek SM; International Breast Cancer Study Group, Bern CH-3008, Switzerland.
  • Feng Y; Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy.
  • Price KN; School of Medical Oncology, The University of Udine, Udine 33100, Italy.
  • Coates AS; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain.
  • Gelber RD; SOLTI Group, Barcelona 08008, Spain.
  • Maruff P; International Breast Cancer Study Group, Bern CH-3008, Switzerland.
  • Boyle F; CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy.
  • Forbes JF; International Breast Cancer Study Group, Bern CH-3008, Switzerland.
  • Ahles T; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden.
  • Fleming GF; Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA.
  • Bernhard J; NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA.
Br J Cancer ; 114(9): 956-64, 2016 04 26.
Article em En | MEDLINE | ID: mdl-27092785
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ovário / Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ovário / Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália